MedPath

A Validation Study of Nitroglycerin Induced Acute Drop of Pd/Pa (NTG-Pd/Pa) in Clinical Practice

Conditions
Hypotension Symptomatic
Ischemic Heart Disease
Registration Number
NCT04700397
Lead Sponsor
National Taiwan University Hospital Hsin-Chu Branch
Brief Summary

Hyperemia with adenosine was an elemental process in FFR examination. Adenosine injection will induce some discomfort, and increase cost expenditure. Nitroglycerine will induce an acute drop of Pd/Pa, and this lowest Pd/Pa was determined as NTG-Pd/Pa. NTG-Pd/Pa has a linear relationship with FFR value and has a good diagnostic accuracy to predict FFR≤0.80 in our recent study. There is only one prospective study report on the relationship between NTG-Pd/Pa and FFR. In this study, we aim to evaluate the safety of NTG-Pd/Pa, the repeatability and dose-response of this novel index. Furthermore, we will investigate the diagnostic accuracy of NTG-Pd/Pa, with FFR≤0.8 and Resting full-cycle ratio≤0.89 as ischemic threshold respectively.

Detailed Description

Fractional flow reserve (FFR) is defined as the ratio of mean distal pressure (distal to the target lesion, Pd)to mean proximal pressure (aortic pressure, Pa) in the coronary artery(Pd/Pa) while the maximal hyperemic flow is achieved. Nowadays, FFR-guided PCI is highly recommended for the assessment of physiologic ischemia in intermediate coronary lesions. However, hyperemia with adenosine was an elemental process in FFR examination. Adenosine injection will induce some discomfort, and increase cost expenditure. Based on the clinical and physiologic outcome study, a lot of non-hyperemic indexes had been proposed, and adenosine injection could be waived. Whereas, these novel physiologic indexes are limited to the proprietary software of each vendor, curtailing clinical application. Intracoronary nitroglycerin injection was needed before each FFR assessment. Nitroglycerine will induce an acute drop of Pd/Pa, and this lowest Pd/Pa was determined as NTG-Pd/Pa. NTG-Pd/Pa has a linear relationship with FFR value and has a good diagnostic accuracy to predict FFR≤0.80 in our recent study. There is only one prospective study report on the relationship between NTG-Pd/Pa and FFR. In this study, we aim to evaluate the safety of NTG-Pd/Pa, the repeatability and dose-response of this novel index. Furthermore, we will investigate the diagnostic accuracy of NTG-Pd/Pa, with FFR≤0.8 and Resting full-cycle ratio≤0.89 as ischemic threshold respectively.

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
100
Inclusion Criteria
  • Eligible for FFR examination
Exclusion Criteria
  • Hypersensitivity to adenosine or nitroglycerine
  • Severe Valvular aortic stenosis
  • Resting heart rate less than 50 beats per minutes
  • Systolic blood pressure less than 100 mmHg or diastolic blood pressure less than 40 mmHg
  • exposure to PDE-5 inhibitors within 48 hours.
  • Recent intracranial hemorrhage or brain injury

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
The repeatability and dose response of NTG-Pd/Pa10 minutes

Comparing the difference of NTG-Pd/Pa value after various dosage of nitroglycerine injection in the same coronary lesion

Secondary Outcome Measures
NameTimeMethod
Diagnostic accuracy of NTG-Pd/Pa 230 minutes

Investigate the diagnostic accuracy of NTG-Pd/Pa, with RFR≤0.89 as ischemic threshold

Diagnostic accuracy of NTG-Pd/Pa 130 minutes

Investigate the diagnostic accuracy of NTG-Pd/Pa, with FFR≤0.8 as ischemic threshold

Major adverse cardiac event2 years

MACE including target lesion failure, target vessel failure, target vessel-related myocardial infarction, and cardiac death

Trial Locations

Locations (1)

National Taiwan University Hospital Hsin-Chu branch

🇨🇳

Hsinchu, Taiwan

National Taiwan University Hospital Hsin-Chu branch
🇨🇳Hsinchu, Taiwan
Chien-Boon Jong, MD
Principal Investigator

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.